Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin S. Hughes, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Beitsch P, Hughes K, Whitworth P. Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al. J Clin Oncol. 2019 Jun 27; JCO1900798. PMID: 31246521.
    Citations:    
  2. Plichta JK, Hughes KS. ASO Author Reflections: The Pressing Need for Germline Genetic Testing. Ann Surg Oncol. 2019 May 16. PMID: 31098782.
    Citations:    
  3. Sippo DA, Burk KS, Mercaldo SF, Rutledge GM, Edmonds C, Guan Z, Hughes KS, Lehman CD. Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications. Radiology. 2019 Jul; 292(1):51-59. PMID: 31063080.
    Citations:    
  4. Plichta JK, Sebastian ML, Smith LA, Menendez CS, Johnson AT, Bays SM, Euhus DM, Clifford EJ, Jalali M, Kurtzman SH, Taylor WA, Hughes KS. Germline Genetic Testing: What the Breast Surgeon Needs to Know. Ann Surg Oncol. 2019 Jul; 26(7):2184-2190. PMID: 30941656.
    Citations:    
  5. Tang R, Kelly BN, Smith BL, Lanahan CR, Brown CL, Gadd MA, Hughes KS, Oseni TO, McGugin C, Specht MC, Coopey SB. Nipple Discharge After Nipple-Sparing Mastectomy With and Without Associated Pregnancy. Clin Breast Cancer. 2019 Mar 15. PMID: 31053520.
    Citations:    
  6. Oseni TO, Zhang B, Coopey SB, Gadd MA, Hughes KS, Chang DC. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women. J Am Coll Surg. 2019 Jun; 228(6):932-939. PMID: 30772444.
    Citations:    
  7. Mastroianni M, Lin A, Hughes K, Colwell AS. Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions. Plast Reconstr Surg. 2019 02; 143(2):271e-275e. PMID: 30489497.
    Citations:    Fields:    
  8. Coopey SB, Kartal K, Li C, Yala A, Barzilay R, Faulkner HR, King TA, Acevedo F, Garber JE, Guidi AJ, Hughes KS. Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk? Breast Cancer Res Treat. 2019 May; 175(1):1-4. PMID: 30666539.
    Citations:    Fields:    
  9. Hughes KS, Beitsch P, Chen S. Guidelines Do Not Proscribe Surgeons Performing Genetic Testing. JAMA Surg. 2018 Dec 12. PMID: 30540356.
    Citations:    Fields:    
  10. Nakhlis F, Harrison BT, Giess CS, Lester SC, Hughes KS, Coopey SB, King TA. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Ann Surg Oncol. 2019 Jan; 26(1):55-61. PMID: 30362065.
    Citations:    Fields:    
  11. Acevedo F, Armengol VD, Deng Z, Tang R, Coopey SB, Braun D, Yala A, Barzilay R, Li C, Colwell A, Guidi A, Cetrulo CL, Garber J, Smith BL, King T, Hughes KS. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat. 2019 Jan; 173(1):201-207. PMID: 30238276.
    Citations:    Fields:    
  12. Roche CA, Tang R, Coopey SB, Hughes KS. Chemoprevention acceptance and adherence in women with high-risk breast lesions. Breast J. 2019 03; 25(2):190-195. PMID: 29785770.
    Citations:    Fields:    
  13. Braun D, Yang J, Griffin M, Parmigiani G, Hughes KS. A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations. J Genet Couns. 2018 09; 27(5):1187-1199. PMID: 29500626.
    Citations: 1     Fields:    
  14. Lamb LR, Bahl M, Hughes KS, Lehman CD. Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography. J Am Coll Surg. 2018 May; 226(5):858-867. PMID: 29410346.
    Citations:    Fields:    
  15. Tang R, Ouyang L, Li C, He Y, Griffin M, Taghian A, Smith B, Yala A, Barzilay R, Hughes K. Machine learning to parse breast pathology reports in Chinese. Breast Cancer Res Treat. 2018 Jun; 169(2):243-250. PMID: 29380208.
    Citations:    Fields:    
  16. Coopey SB, Acar A, Griffin M, Cintolo-Gonzalez J, Semine A, Hughes KS. The impact of patient age on breast cancer risk prediction models. Breast J. 2018 07; 24(4):592-598. PMID: 29316072.
    Citations:    Fields:    
  17. Hughes KS. Reply to E. Ramos et al. J Clin Oncol. 2018 Feb 10; 36(5):520. PMID: 29293390.
    Citations:    Fields:    
  18. Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes KS, Isakoff SJ, Ellisen LW, Smith BL, Specht M, Moy B, Bardia A. Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. J Natl Compr Canc Netw. 2017 10; 15(10):1216-1223. PMID: 28982747.
    Citations:    Fields:    Translation:Humans
  19. Hughes KS. Genetic Testing: What Problem Are We Trying to Solve? J Clin Oncol. 2017 12 01; 35(34):3789-3791. PMID: 28820645.
    Citations: 3     Fields:    
  20. Cintolo-Gonzalez JA, Braun D, Blackford AL, Mazzola E, Acar A, Plichta JK, Griffin M, Hughes KS. Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat. 2017 08; 164(3):745. PMID: 28639028.
    Citations:    Fields:    
  21. Hughes KS, Ambinder EP, Hess GP, Yu PP, Bernstam EV, Routbort MJ, Clemenceau JR, Hamm JT, Febbo PG, Domchek SM, Chen JL, Warner JL. Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop. J Clin Oncol. 2017 Sep 20; 35(27):3153-3159. PMID: 28737972.
    Citations: 5     Fields:    Translation:Humans
  22. Mazzola E, Coopey SB, Griffin M, Polubriaginof F, Buckley JM, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi A, Hughes KS. Reassessing risk models for atypical hyperplasia: age may not matter. Breast Cancer Res Treat. 2017 Sep; 165(2):285-291. PMID: 28589368.
    Citations: 1     Fields:    Translation:Humans
  23. Cintolo-Gonzalez JA, Braun D, Blackford AL, Mazzola E, Acar A, Plichta JK, Griffin M, Hughes KS. Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat. 2017 Jul; 164(2):263-284. PMID: 28444533.
    Citations: 1     Fields:    Translation:Humans
  24. Yala A, Barzilay R, Salama L, Griffin M, Sollender G, Bardia A, Lehman C, Buckley JM, Coopey SB, Polubriaginof F, Garber JE, Smith BL, Gadd MA, Specht MC, Gudewicz TM, Guidi AJ, Taghian A, Hughes KS. Using machine learning to parse breast pathology reports. Breast Cancer Res Treat. 2017 01; 161(2):203-211. PMID: 27826755.
    Citations: 3     Fields:    Translation:Humans
  25. Plichta JK, Griffin M, Thakuria J, Hughes KS. What's New in Genetic Testing for Cancer Susceptibility? Oncology (Williston Park). 2016 09 15; 30(9):787-99. PMID: 27633409.
    Citations: 2     Fields:    Translation:Humans
  26. Plichta JK, Rai U, Tang R, Coopey SB, Buckley JM, Gadd MA, Specht MC, Hughes KS, Taghian AG, Smith BL. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Ann Surg Oncol. 2016 10; 23(10):3212-20. PMID: 27406095.
    Citations: 2     Fields:    Translation:Humans
  27. Clifford E, Hughes KS, Roberts M, Pirzadeh-Miller S, McLaughlin SA. Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer. Ann Surg Oncol. 2016 10; 23(10):3128-32. PMID: 27401444.
    Citations:    Fields:    Translation:Humans
  28. Throckmorton AD, Rhodes DJ, Hughes KS, Degnim AC, Dickson-Witmer D. Dense Breasts: What Do Our Patients Need to Be Told and Why? Ann Surg Oncol. 2016 10; 23(10):3119-27. PMID: 27401446.
    Citations:    Fields:    Translation:Humans
  29. Merrill AL, Tang R, Plichta JK, Rai U, Coopey SB, McEvoy MP, Hughes KS, Specht MC, Gadd MA, Smith BL. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins. Ann Surg Oncol. 2016 10; 23(11):3453-3458. PMID: 27207096.
    Citations: 3     Fields:    Translation:Humans
  30. Biswas S, Atienza P, Chipman J, Blackford AL, Arun B, Hughes K, Parmigiani G. A two-stage approach to genetic risk assessment in primary care. Breast Cancer Res Treat. 2016 Jan; 155(2):375-83. PMID: 26786860.
    Citations: 1     Fields:    Translation:Humans
  31. Krauss JC, Warner JL, Maddux SE, Brown JR, Moldwin R, Schorer AE, Hughes KS, Ambinder EP. Data Sharing to Support the Cancer Journey in the Digital Era. J Oncol Pract. 2016 Mar; 12(3):201-7. PMID: 26759494.
    Citations: 2     Fields:    Translation:Humans
  32. Mattos D, Gfrerer L, Reish RG, Hughes KS, Cetrulo C, Colwell AS, Winograd JM, Yaremchuk MJ, Austen WG, Liao EC. Lifetime Costs of Prophylactic Mastectomies and Reconstruction versus Surveillance. Plast Reconstr Surg. 2015 Dec; 136(6):730e-40e. PMID: 26595028.
    Citations: 2     Fields:    Translation:Humans
  33. Sarraj WM, Tang R, Najjar AL, Griffin M, Bui AH, Zambeli-Ljepovic A, Senter-Zapata M, Lewin-Berlin M, Fernandez L, Buckley J, Ly A, Brachtel E, Aftreth O, Gilbertson J, Yagi Y, Gadd M, Hughes KS, Smith BL, Michaelson JS. Prediction of primary breast cancer size and T-stage using micro-computed tomography in lumpectomy specimens. J Pathol Inform. 2015; 6:60. PMID: 26730350.
    Citations: 2     
  34. Mattos D, Gfrerer L, Ling IT, Reish RG, Hughes KS, Halpern EF, Cetrulo C, Colwell AS, Winograd JM, Yaremchuk MJ, Austen WG, Liao EC. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies. Ann Surg Oncol. 2016 Mar; 23(3):767-75. PMID: 26577123.
    Citations:    Fields:    Translation:Humans
  35. Moskos MM, Hughes KS. Doing "nothing" for DCIS: a case report. Breast Cancer Res Treat. 2015 Nov; 154(2):435-7. PMID: 26498020.
    Citations:    Fields:    Translation:Humans
  36. Merrill AL, Coopey SB, Tang R, McEvoy MP, Specht MC, Hughes KS, Gadd MA, Smith BL. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor. Ann Surg Oncol. 2016 Mar; 23(3):729-34. PMID: 26467458.
    Citations: 3     Fields:    Translation:Humans
  37. Chan CH, Coopey SB, Freer PE, Hughes KS. False-negative rate of combined mammography and ultrasound for women with palpable breast masses. Breast Cancer Res Treat. 2015 Oct; 153(3):699-702. PMID: 26341750.
    Citations:    Fields:    Translation:Humans
  38. Freer PE, Slanetz PJ, Haas JS, Tung NM, Hughes KS, Armstrong K, Semine AA, Troyan SL, Birdwell RL. Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel. Breast Cancer Res Treat. 2015 Sep; 153(2):455-64. PMID: 26290416.
    Citations: 3     Fields:    Translation:Humans
  39. Hughes KS, Cusack JC. Genetics, Genomics, and Pharmacogenomics. Ann Surg Oncol. 2015 Oct; 22(11):3414-7. PMID: 26215191.
    Citations:    Fields:    Translation:Humans
  40. Hughes KS, Schnaper LA. Can older women with early breast cancer avoid radiation? Lancet Oncol. 2015 Mar; 16(3):235-7. PMID: 25637341.
    Citations:    Fields:    Translation:Humans
  41. Punglia RS, Hughes KS, Muss HB. Management of older women with early-stage breast cancer. Am Soc Clin Oncol Educ Book. 2015; 48-55. PMID: 25993142.
    Citations: 2     Fields:    Translation:Humans
  42. Tang R, Coopey SB, Specht MC, Lei L, Gadd MA, Hughes KS, Brachtel EF, Smith BL. Lumpectomy specimen margins are not reliable in predicting residual disease in breast conserving surgery. Am J Surg. 2015 Jul; 210(1):93-8. PMID: 25613784.
    Citations: 3     Fields:    Translation:Humans
  43. Wood ME, Lu KH, Wollins DS, Hughes KS. Reply to A.S. Sie et al, K. Hemminki et al, and J. Larsen Haidle. J Clin Oncol. 2014 Oct 10; 32(29):3346-7. PMID: 25185101.
    Citations:    Fields:    Translation:Humans
  44. Miller CL, West JA, Bettini AC, Koerner FC, Gudewicz TM, Freer PE, Coopey SB, Gadd MA, Hughes KS, Smith BL, Rafferty E, Specht MC. Surgical excision of radial scars diagnosed by core biopsy may help predict future risk of breast cancer. Breast Cancer Res Treat. 2014 Jun; 145(2):331-8. PMID: 24748568.
    Citations: 4     Fields:    Translation:Humans
  45. Edelman EA, Lin BK, Doksum T, Drohan B, Edelson V, Dolan SM, Hughes KS, O'Leary J, Galvin SL, Degroat N, Pardanani S, Feero WG, Adams C, Jones R, Scott J. Implementation of an electronic genomic and family health history tool in primary prenatal care. Am J Med Genet C Semin Med Genet. 2014 Mar; 166C(1):34-44. PMID: 24616345.
    Citations: 3     Fields:    Translation:Humans
  46. Wood ME, Kadlubek P, Pham TH, Wollins DS, Lu KH, Weitzel JN, Neuss MN, Hughes KS. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol. 2014 Mar 10; 32(8):824-9. PMID: 24493722.
    Citations: 31     Fields:    Translation:Humans
  47. Lu KH, Wood ME, Daniels M, Burke C, Ford J, Kauff ND, Kohlmann W, Lindor NM, Mulvey TM, Robinson L, Rubinstein WS, Stoffel EM, Snyder C, Syngal S, Merrill JK, Wollins DS, Hughes KS. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol. 2014 Mar 10; 32(8):833-40. PMID: 24493721.
    Citations: 33     Fields:    Translation:Humans
  48. Fitzgibbons PL, Dillon DA, Alsabeh R, Berman MA, Hayes DF, Hicks DG, Hughes KS, Nofech-Mozes S. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. Arch Pathol Lab Med. 2014 May; 138(5):595-601. PMID: 24236805.
    Citations: 8     Fields:    Translation:Humans
  49. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al. J Clin Oncol. 2013 Dec 20; 31(36):4571-3. PMID: 24190113.
    Citations:    Fields:    Translation:Humans
  50. Hughes KS, Krauss JC, Maddux S, Yu PP, Ambinder EP. An interoperable HL7 document standard to improve the quality of cancer care across multiple locations. J Clin Oncol. 2013 Nov; 31(31_suppl):12. PMID: 28136420.
    Citations:    
  51. Drohan B, Hughes KS. Breast cancer risk assessment: How risk models can "overdiagnose" risk. J Clin Oncol. 2013 Nov; 31(31_suppl):184. PMID: 28136473.
    Citations:    
  52. Chipman J, Drohan B, Blackford A, Parmigiani G, Hughes K, Bosinoff P. Providing access to risk prediction tools via the HL7 XML-formatted risk web service. Breast Cancer Res Treat. 2013 Jul; 140(1):187-93. PMID: 23793601.
    Citations: 3     Fields:    Translation:Humans
  53. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013 Jul 01; 31(19):2382-7. PMID: 23690420.
    Citations: 100     Fields:    Translation:Humans
  54. Lin BK, Edelman E, McInerney JD, O'Leary J, Edelson V, Hughes KS, Drohan B, Kyler P, Lloyd-Puryear M, Scott J, Dolan SM. Personalizing prenatal care using family health history: identifying a panel of conditions for a novel electronic genetic screening tool. Per Med. 2013 May; 10(3):307-318. PMID: 29768747.
    Citations:    
  55. Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, Polubriaginof F, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi AJ, Roche CA, Hughes KS. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012 Dec; 136(3):627-33. PMID: 23117858.
    Citations: 22     Fields:    Translation:Humans
  56. Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS. Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):146-9. PMID: 23093547.
    Citations: 9     Fields:    Translation:Humans
  57. Camp MS, Greenup RA, Taghian A, Coopey SB, Specht M, Gadd M, Hughes K, Smith BL. Application of ACOSOG Z0011 criteria reduces perioperative costs. Ann Surg Oncol. 2013 Mar; 20(3):836-41. PMID: 23010735.
    Citations: 3     Fields:    Translation:Humans
  58. Hughes KS. A program to increase use of chemoprevention for women with high-risk breast lesions. J Clin Oncol. 2012 Sep 20; 30(27_suppl):46. PMID: 28146755.
    Citations:    
  59. Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, O'Toole J, Coopey SB, Hughes K, Gadd M, Smith BL, Taghian AG. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat. 2012 Oct; 135(3):781-9. PMID: 22941538.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  60. Greenup RA, Camp MS, Taghian AG, Buckley J, Coopey SB, Gadd M, Hughes K, Specht M, Smith BL. Cost comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol. 2012 Oct; 19(10):3275-81. PMID: 22851048.
    Citations: 11     Fields:    Translation:Humans
  61. Schwartz GF, Bartelink H, Burstein HJ, Cady B, Cataliotti L, Fentiman IS, Holland R, Hughes KS, Masood S, McCormick B, Palazzo JA, Pressman PI, Reis-Filho J, Pusztai L, Rutgers EJ, Seidman AD, Solin LJ, Sparano JA. Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping. Breast J. 2012 Jul-Aug; 18(4):303-11. PMID: 22759093.
    Citations: 2     Fields:    Translation:HumansCells
  62. Buckley JM, Coopey SB, Sharko J, Polubriaginof F, Drohan B, Belli AK, Kim EM, Garber JE, Smith BL, Gadd MA, Specht MC, Roche CA, Gudewicz TM, Hughes KS. The feasibility of using natural language processing to extract clinical information from breast pathology reports. J Pathol Inform. 2012; 3:23. PMID: 22934236.
    Citations: 14     
  63. Kadlubek P, Lu KH, Wollins D, Weitzel JN, Neuss MN, Hughes KS. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: A pilot test of quality measures as part of the ASCO Quality Oncology Practice Initiative (QOPI). J Clin Oncol. 2012 Jun 20; 30(18_suppl):CRA1505. PMID: 28140820.
    Citations:    
  64. Cusack JC, Hughes KS. Managing patients at high risk for hereditary breast cancer: a guide for the practicing physician. Ann Surg Oncol. 2012 Jun; 19(6):1721-2. PMID: 22411203.
    Citations: 1     Fields:    Translation:Humans
  65. Drohan B, Roche CA, Cusack JC, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012 Jun; 19(6):1732-7. PMID: 22427173.
    Citations: 12     Fields:    Translation:Humans
  66. Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat. 2012 Jun; 133(2):735-40. PMID: 22240989.
    Citations: 16     Fields:    Translation:Humans
  67. Krenitsky VP, Delgado M, Nadolny L, Sahasrabudhe K, Ayala L, Clareen SS, Hilgraf R, Albers R, Kois A, Hughes K, Wright J, Nowakowski J, Sudbeck E, Ghosh S, Bahmanyar S, Chamberlain P, Muir J, Cathers BE, Giegel D, Xu L, Celeridad M, Moghaddam M, Khatsenko O, Omholt P, Katz J, Pai S, Fan R, Tang Y, Shirley MA, Benish B, Blease K, Raymon H, Bhagwat S, Henderson I, Cole AG, Bennett B, Satoh Y. Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury. Bioorg Med Chem Lett. 2012 Feb 01; 22(3):1427-32. PMID: 22226655.
    Citations: 5     Fields:    Translation:AnimalsCells
  68. Coopey SB, Buckley JM, Smith BL, Hughes KS, Gadd MA, Specht MC. Lumpectomy cavity shaved margins do not impact re-excision rates in breast cancer patients. Ann Surg Oncol. 2011 Oct; 18(11):3036-40. PMID: 21947583.
    Citations: 9     Fields:    Translation:Humans
  69. Coopey S, Smith BL, Hanson S, Buckley J, Hughes KS, Gadd M, Specht MC. The safety of multiple re-excisions after lumpectomy for breast cancer. Ann Surg Oncol. 2011 Dec; 18(13):3797-801. PMID: 21630123.
    Citations: 4     Fields:    Translation:Humans
  70. Hughes KS, Roche CA. The complexity of breast cancer risk needs to be embraced, not oversimplified. Menopause. 2011 Jun; 18(6):599-600. PMID: 21587090.
    Citations:    Fields:    Translation:HumansPHPublic Health
  71. Samphao S, Wheeler AJ, Rafferty E, Michaelson JS, Specht MC, Gadd MA, Hughes KS, Smith BL. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009 Oct; 198(4):538-43. PMID: 19800464.
    Citations: 11     Fields:    Translation:Humans
  72. Javid SH, Kirstein LJ, Rafferty E, Lipsitz S, Moore R, Rusby JE, Murphy CD, Hughes KS, Specht MC, Taghian AG, Smith BL. Outcome of multiple-wire localization for larger breast cancers: do multiple wires translate into additional imaging, biopsies, and recurrences? Am J Surg. 2009 Sep; 198(3):368-72. PMID: 19716884.
    Citations: 1     Fields:    Translation:Humans
  73. Drohan B, Ozanne EM, Hughes KS. Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J. 2009 Sep-Oct; 15 Suppl 1:S46-55. PMID: 19775330.
    Citations: 8     Fields:    Translation:Humans
  74. Alm El-Din MA, Hughes KS, Raad RA, Goldberg SI, Aisenberg AC, Niemierko A, Taghian AG. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis. Radiat Oncol. 2009 Jun 30; 4:19. PMID: 19566943.
    Citations: 2     Fields:    Translation:Humans
  75. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J. 2009 Mar-Apr; 15(2):155-62. PMID: 19292801.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  76. Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ, Anderson BO, Arun BK, Bartelink H, Bernard P, Bonanni B, Cady B, Clough KB, Feig SA, Heywang-Köbrunner SH, Howell A, Isaacs C, Kopans DB, Mansel RE, Masood S, Palazzo JP, Pressman PI, Solin LJ, Untch M. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J. 2009 Jan-Feb; 15(1):4-16. PMID: 19141130.
    Citations: 8     Fields:    Translation:Humans
  77. Murphy CD, Lee JM, Drohan B, Euhus DM, Kopans DB, Gadd MA, Rafferty EA, Specht MC, Smith BL, Hughes KS. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer. 2008 Dec 01; 113(11):3116-20. PMID: 18932252.
    Citations: 5     Fields:    Translation:Humans
  78. Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Cancer. 2008 Nov 15; 113(10):2627-37. PMID: 18853415.
    Citations: 32     Fields:    Translation:Humans
  79. Murphy CD, Jones JL, Javid SH, Michaelson JS, Nolan ME, Lipsitz SR, Specht MC, Lesnikoski BA, Hughes KS, Gadd MA, Smith BL. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am J Surg. 2008 Oct; 196(4):566-8. PMID: 18760400.
    Citations: 4     Fields:    Translation:Humans
  80. Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG. Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):69-74. PMID: 18538497.
    Citations: 10     Fields:    Translation:Humans
  81. Kirstein LJ, Rafferty E, Specht MC, Moore RH, Taghian AG, Hughes KS, Gadd MA, Smith BL. Outcomes of multiple wire localization for larger breast cancers: when can mastectomy be avoided? J Am Coll Surg. 2008 Sep; 207(3):342-6. PMID: 18722938.
    Citations: 2     Fields:    Translation:Humans
  82. Hughes KS. Why do we believe that breast cancer in the elderly is the same as breast cancer in young women? Drugs Aging. 2008; 25(1):47-8. PMID: 18184028.
    Citations:    Fields:    Translation:Humans
  83. Carlson RW, Moench S, Hurria A, Balducci L, Burstein HJ, Goldstein LJ, Gradishar WJ, Hughes KS, Jahanzeb M, Lichtman SM, Marks LB, McClure JS, McCormick B, Nabell LM, Pierce LJ, Smith ML, Topham NS, Traina TA, Ward JH, Winer EP. NCCN Task Force Report: breast cancer in the older woman. J Natl Compr Canc Netw. 2008; 6 Suppl 4:S1-25; quiz S26-7. PMID: 18597715.
    Citations: 17     Fields:    Translation:Humans
  84. Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol. 2008 Jan; 15(1):268-73. PMID: 17891441.
    Citations: 9     Fields:    Translation:Humans
  85. Black D, Specht M, Lee JM, Dominguez F, Gadd M, Hughes K, Rafferty E, Smith B. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol. 2007 Sep; 14(9):2477-84. PMID: 17587091.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  86. Dominguez FJ, Lawrence C, Halpern EF, Drohan B, Grinstein G, Black DM, Smith BL, Gadd MA, Specht M, Kopans DB, Moore RH, Hughes SS, Roche CA, Hughes KS. Accuracy of self-reported personal history of cancer in an outpatient breast center. J Genet Couns. 2007 Jun; 16(3):341-5. PMID: 17508275.
    Citations: 12     Fields:    Translation:Humans
  87. del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS. Mammographic breast density and race. AJR Am J Roentgenol. 2007 Apr; 188(4):1147-50. PMID: 17377060.
    Citations: 33     Fields:    Translation:Humans
  88. Kozak KR, Smith BL, Adams J, Kornmehl E, Katz A, Gadd M, Specht M, Hughes K, Gioioso V, Lu HM, Braaten K, Recht A, Powell SN, DeLaney TF, Taghian AG. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):691-8. PMID: 17011445.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  89. Dominguez FJ, Black DM, Kawaguchi AL, O'Malley CA, Hughes KS. Elastic stay hooks and self-retaining retractor technique for mastectomy skin flaps. Surgery. 2007 Feb; 141(2):272-4. PMID: 17263986.
    Citations: 3     Fields:    Translation:Humans
  90. Blanchard K, Colbert JA, Kopans DB, Moore R, Halpern EF, Hughes KS, Smith BL, Tanabe KK, Michaelson JS. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use. Radiology. 2006 Aug; 240(2):335-42. PMID: 16864665.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  91. Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, Holland R, Hughes KS, Mansel RE, Margolese R, Mendelson EB, Olivotto IA, Palazzo JP, Solin LJ. Consensus conference on breast conservation. J Am Coll Surg. 2006 Aug; 203(2):198-207. PMID: 16864033.
    Citations: 11     Fields:    Translation:Humans
  92. Zabicki K, Colbert JA, Dominguez FJ, Gadd MA, Hughes KS, Jones JL, Specht MC, Michaelson JS, Smith BL. Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol. 2006 Aug; 13(8):1072-7. PMID: 16865599.
    Citations: 17     Fields:    Translation:Humans
  93. Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, Holland R, Hughes KS, Mansel RE, Margolese R, Mendelson EB, Olivotto IA, Palazzo JP, Solin LJ. Consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Breast J. 2006 Jul-Aug; 12(4):398-407. PMID: 16848863.
    Citations: 3     Fields:    
  94. Taghian AG, Kozak KR, Doppke KP, Katz A, Smith BL, Gadd M, Specht M, Hughes K, Braaten K, Kachnic LA, Recht A, Powell SN. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1092-9. PMID: 16406392.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  95. Shi AA, Georgian-Smith D, Cornell LD, Rafferty EA, Staffa M, Hughes K, Kopans DB. Radiological reasoning: male breast mass with calcifications. AJR Am J Roentgenol. 2005 Dec; 185(6 Suppl):S205-10. PMID: 16304041.
    Citations: 4     Fields:    Translation:Humans
  96. Dominguez FJ, Jones JL, Zabicki K, Smith BL, Gadd MA, Specht M, Kopans DB, Moore RH, Michaelson JS, Hughes KS. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. Cancer. 2005 Nov 01; 104(9):1849-53. PMID: 16136597.
    Citations: 8     Fields:    Translation:Humans
  97. Jones JL, Zabicki K, Christian RL, Gadd MA, Hughes KS, Lesnikoski BA, Rhei E, Specht MC, Dominguez FJ, Smith BL. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg. 2005 Oct; 190(4):517-20. PMID: 16164912.
    Citations: 6     Fields:    Translation:Humans
  98. Jones JL, Hughes KS, Kopans DB, Moore RH, Howard-McNatt M, Hughes SS, Lee NY, Roche CA, Siegel N, Gadd MA, Smith BL, Michaelson JS. Evaluation of hereditary risk in a mammography population. Clin Breast Cancer. 2005 Apr; 6(1):38-44. PMID: 15899071.
    Citations: 9     Fields:    Translation:Humans
  99. Katz MS, Schapira L, Harisinghani MG, Hughes KS. Palpable right breast mass in a pregnant woman. Nat Clin Pract Oncol. 2005 Apr; 2(4):218-21; quiz 1 p following 222. PMID: 16264937.
    Citations: 1     Fields:    Translation:Humans
  100. Howard-McNatt M, Hughes KS, Schnaper LA, Jones JL, Gadd M, Smith BL. Breast cancer treatment in older women. Surg Oncol Clin N Am. 2005 Jan; 14(1):85-102, vi. PMID: 15542001.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  101. Colbert JA, Kaine EM, Bigby J, Smith DN, Moore RH, Rafferty E, Georgian-Smith D, Anne D'Alessandro H, Yeh E, Kopans DB, Halpern EF, Hughes K, Smith BL, Tanabe KK, Michaelson JS. The age at which women begin mammographic screening. Cancer. 2004 Oct 15; 101(8):1850-9. PMID: 15386333.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  102. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004 Sep 02; 351(10):971-7. PMID: 15342805.
    Citations: 126     Fields:    Translation:HumansCTClinical Trials
  103. Blanchard K, Colbert JA, Puri D, Weissman J, Moy B, Kopans DB, Kaine EM, Moore RH, Halpern EF, Hughes KS, Tanabe KK, Smith BL, Michaelson JS. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer. 2004 Aug 01; 101(3):495-507. PMID: 15274062.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  104. Michaelson JS, Silverstein M, Sgroi D, Cheongsiatmoy JA, Taghian A, Powell S, Hughes K, Comegno A, Tanabe KK, Smith B. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer. 2003 Nov 15; 98(10):2133-43. PMID: 14601082.
    Citations: 25     Fields:    Translation:Humans
  105. Michaelson JS, Satija S, Kopans D, Moore R, Silverstein M, Comegno A, Hughes K, Taghian A, Powell S, Smith B. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer. 2003 Nov 15; 98(10):2114-24. PMID: 14601080.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  106. del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J. Racial differences in mammographic breast density. Cancer. 2003 Aug 01; 98(3):590-6. PMID: 12879477.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  107. Hughes KS, Roche CA. Hormone therapy revisited: data from the population, treatment for the patient. Menopause. 2003 Jul-Aug; 10(4):269-70. PMID: 12851507.
    Citations:    Fields:    Translation:Humans
  108. Kopans DB, Rafferty E, Georgian-Smith D, Yeh E, D'Alessandro H, Moore R, Hughes K, Halpern E. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer. 2003 Jun 15; 97(12):2951-9. PMID: 12784329.
    Citations: 7     Fields:    Translation:Humans
  109. Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J. 2003 Jan-Feb; 9(1):19-25. PMID: 12558666.
    Citations: 11     Fields:    Translation:Humans
  110. Michaelson JS, Silverstein M, Wyatt J, Weber G, Moore R, Halpern E, Kopans DB, Hughes K. Predicting the survival of patients with breast carcinoma using tumor size. Cancer. 2002 Aug 15; 95(4):713-23. PMID: 12209713.
    Citations: 18     Fields:    Translation:Humans
  111. Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P, Esserman L, Crawford B, Hughes KS, Roche CA, Ganz PA, Seldon J, Fabian CJ, Klemp J, Tomlinson G. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst. 2002 Jun 05; 94(11):844-51. PMID: 12048272.
    Citations: 42     Fields:    Translation:Humans
  112. Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002 Jun 01; 20(11):2701-12. PMID: 12039933.
    Citations: 111     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hughes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (272)
Explore
_
Co-Authors (82)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.